Drug Type Bispecific antibody |
Synonyms |
Target |
Mechanism BAK inhibitors(BCL2 antagonist/killer 1 inhibitors), DNA inhibitors(DNA inhibitors), Apoptosis regulatory proteins stimulants |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Breast Cancer | Discovery | AU | - | |
Breast Cancer | Discovery | AU | - |